Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
MVC-COV1901
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/29/2020
S96
Potential treatment - pre-clinical evidence Experimental Antiviral
PCI-27483
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
mAb Beta-22
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
NSC Ex/Mv
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/18/2020
Y-320
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
BRII-196
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Full-length Spike protein
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/29/2021
STE73-2E9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/11/2021
Emetine
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Avoralstat
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
Adjuvanted SARS-CoV-2 Spike protein
Potential treatment - pre-clinical evidence Experimental Vaccine Apr/01/2021
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
Azanitrile 8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
Pyridyl ester 17
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
GRL0617
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/20/2021
J08-MUT
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/23/2021
VS12
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Bis4
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
Bis3
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021